 Double-Blind Method
"Double-Blind Method" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
| Descriptor ID |
D004311
|
| MeSH Number(s) |
E05.318.780.300 E05.581.500.300 N05.715.360.780.320 N06.850.520.445.300
|
| Concept/Terms |
Double-Blind Method- Double-Blind Method
- Double Blind Method
- Double-Blind Methods
- Method, Double-Blind
- Methods, Double-Blind
- Double-Masked Method
- Double Masked Method
- Double-Masked Methods
- Method, Double-Masked
- Methods, Double-Masked
- Double-Masked Study
- Double Masked Study
- Double-Masked Studies
- Studies, Double-Masked
- Study, Double-Masked
- Double-Blind Study
- Double Blind Study
- Double-Blind Studies
- Studies, Double-Blind
- Study, Double-Blind
|
Below are MeSH descriptors whose meaning is more general than "Double-Blind Method".
Below are MeSH descriptors whose meaning is more specific than "Double-Blind Method".
This graph shows the total number of publications written about "Double-Blind Method" by people in this website by year, and whether "Double-Blind Method" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 17 | 17 | | 1997 | 0 | 17 | 17 | | 1998 | 0 | 18 | 18 | | 1999 | 0 | 19 | 19 | | 2000 | 0 | 18 | 18 | | 2001 | 0 | 23 | 23 | | 2002 | 0 | 26 | 26 | | 2003 | 1 | 28 | 29 | | 2004 | 0 | 40 | 40 | | 2005 | 0 | 36 | 36 | | 2006 | 0 | 43 | 43 | | 2007 | 0 | 34 | 34 | | 2008 | 0 | 46 | 46 | | 2009 | 0 | 50 | 50 | | 2010 | 0 | 47 | 47 | | 2011 | 0 | 55 | 55 | | 2012 | 0 | 55 | 55 | | 2013 | 0 | 57 | 57 | | 2014 | 1 | 84 | 85 | | 2015 | 0 | 72 | 72 | | 2016 | 0 | 83 | 83 | | 2017 | 0 | 79 | 79 | | 2018 | 0 | 80 | 80 | | 2019 | 0 | 83 | 83 | | 2020 | 0 | 81 | 81 | | 2021 | 0 | 69 | 69 | | 2022 | 0 | 48 | 48 | | 2023 | 0 | 52 | 52 | | 2024 | 0 | 71 | 71 | | 2025 | 0 | 100 | 100 | | 2026 | 0 | 43 | 43 |
To return to the timeline, click here.
Below are the most recent publications written about "Double-Blind Method" by people in Profiles.
-
Xiang AH, Hwang CK, Clennon E, To T, Pyrzanowski J, Calderon AB, Wilson S, Shields E, Beltran G, Sevick C, Bock M, Harris KT, Rove KO. Safety of short-term non-steroidal anti-inflammatory drug use in the postoperative setting in paediatric patients with chronic kidney disease: protocol for a randomised, placebo-controlled trial. BMJ Open. 2026 Sep 18; 16(9):e120782.
-
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.
-
Paik WH, Huh G, Choi YH, Choi JH, Cho IR, Lee SH, Ryu JK, Kim HJ, Lee T, Park CH, Lee Y, Cho SH, Seo DW, Lee KH, Lee KT, Lee JK, Jang S, Vargo J, Edmundowicz S, Park JK, Park DH. Acetate- Versus Lactate-Buffered Crystalloids for Prevention of Post-ERCP Pancreatitis in Patients Without Access to Rectal NSAIDs: A Multicentre Double-Blind Randomized Trial. United European Gastroenterol J. 2026 Sep; 14(7):e70281.
-
Mitchell JJ, Abdenur JE, de Boer F, Boyer M, Breilyn MS, Couce ML, De Leon DD, Derks TG, El-Gharbawy A, Haijer-Schreuder AB, Loechner K, Longo N, Lund AM, Olmos MAM, McCandless SE, de Oliveira BM, Mount M, Muschol N, Pytlak K, Radhakrishnan K, Riba-Wolman R, Rodriguez-Buritica DF, La Rosa A, Rossi A, Saavedra H, Santer R, Shayota B, Smit GPA, Moura De Souza CF, van der Klauw MM, Weinstein DA, Wolfsdorf JI, Blake A, Grimm AA, Mitragotri D, Rahman S, Turner-Bowker DM, Collis R. Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa. J Inherit Metab Dis. 2026 Sep; 49(5):e70241.
-
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.
-
Abovich A, Fontana M, Claggett B, Gillmore JD, Cappelli F, Ambardekar AV, Morbach C, Garcia-Pavia P, Witteles RM, Maurer MS, Jay PY, Kosheleff A, Bansilal S, Solomon SD. Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2026 Sep 22; 88(12):1416-1424.
-
Bonaca MP, Canonico ME, Li N, Sasiela WJ, Nissen SE, Lincoff AM, Nicholls SJ. Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial. Circulation. 2026 Sep 15; 154(11):966-975.
-
Grandi SM, Mumford SL, Hinkle SN, Tailor LS, Sjaarda LA, Flanagan KS, Aston KI, Jenkins T, Hotaling J, Johnstone EB, Van Voorhis BJ, Ryan G, Perkins NJ, Schisterman EF. Elevated lipid levels and altered semen parameters in men of couples seeking fertility care. Am J Epidemiol. 2026 08 05; 195(8):2179-2190.
-
Wilson PT, Tanverdi M, Brinton JT, Ambroggio L, Szefler SJ. Bilevel Positive Airway Pressure and Continuous Albuterol for Pediatric Asthma Exacerbations: A Randomized Clinical Trial. JAMA Netw Open. 2026 08 03; 9(8):e2630627.
-
van Baar MJB, Bjornstad P, Touw DJ, Joles JA, Krebber MM, Cherney DZI, van Raalte DH, Muskiet MHA. Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials. Nephrol Dial Transplant. 2026 Jul 31; 41(8):1520-1528.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|